AU4645293A - The met proto-oncogene and a method for predicting breast cancer progression - Google Patents
The met proto-oncogene and a method for predicting breast cancer progressionInfo
- Publication number
- AU4645293A AU4645293A AU46452/93A AU4645293A AU4645293A AU 4645293 A AU4645293 A AU 4645293A AU 46452/93 A AU46452/93 A AU 46452/93A AU 4645293 A AU4645293 A AU 4645293A AU 4645293 A AU4645293 A AU 4645293A
- Authority
- AU
- Australia
- Prior art keywords
- oncogene
- breast cancer
- cancer progression
- met proto
- predicting breast
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/57415—Specifically defined cancers of breast
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/82—Translation products from oncogenes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/32—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against translation products of oncogenes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/5748—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving oncogenic proteins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/118—Prognosis of disease development
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Oncology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Genetics & Genomics (AREA)
- Pathology (AREA)
- Analytical Chemistry (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Hospice & Palliative Care (AREA)
- Biophysics (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Food Science & Technology (AREA)
- Cell Biology (AREA)
- General Physics & Mathematics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US07/903,588 US6673559B1 (en) | 1989-12-27 | 1992-06-26 | Met proto-oncogene and a method for predicting breast cancer progression |
US903588 | 1992-06-26 | ||
PCT/US1993/005952 WO1994000764A1 (en) | 1992-06-26 | 1993-06-25 | The met proto-oncogene and a method for predicting breast cancer progression |
Publications (1)
Publication Number | Publication Date |
---|---|
AU4645293A true AU4645293A (en) | 1994-01-24 |
Family
ID=25417739
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU46452/93A Abandoned AU4645293A (en) | 1992-06-26 | 1993-06-25 | The met proto-oncogene and a method for predicting breast cancer progression |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU4645293A (en) |
WO (1) | WO1994000764A1 (en) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE69521002T3 (en) * | 1994-08-12 | 2010-02-25 | The University Of Utah Research Foundation, Salt Lake City | Mutations of the 17q associated ovarian and breast cancer susceptibility gene |
US5709999A (en) * | 1994-08-12 | 1998-01-20 | Myriad Genetics Inc. | Linked breast and ovarian cancer susceptibility gene |
CA2196790C (en) * | 1994-08-12 | 2000-10-10 | Mark H. Skolnick | 17q-linked breast and ovarian cancer susceptibility gene |
US5753441A (en) * | 1994-08-12 | 1998-05-19 | Myriad Genetics, Inc. | 170-linked breast and ovarian cancer susceptibility gene |
US5747282A (en) * | 1994-08-12 | 1998-05-05 | Myraid Genetics, Inc. | 17Q-linked breast and ovarian cancer susceptibility gene |
US5693473A (en) * | 1994-08-12 | 1997-12-02 | Myriad Genetics, Inc. | Linked breast and ovarian cancer susceptibility gene |
US6573043B1 (en) | 1998-10-07 | 2003-06-03 | Genentech, Inc. | Tissue analysis and kits therefor |
IL131142A0 (en) * | 1999-07-28 | 2001-01-28 | Rad Ramot | Prognosis of breast cancer and other diseases |
CA2791863C (en) | 2010-03-10 | 2022-06-21 | Genmab A/S | Monoclonal antibodies against c-met |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU3568289A (en) * | 1988-04-18 | 1989-11-24 | Applied Biotechnology, Inc. | Detection of neu gene expression and products |
WO1991009974A1 (en) * | 1989-12-27 | 1991-07-11 | The United States Of America, As Represented By The Secretary, U.S. Department Of Commerce | Diagnostic probe for detecting human stomach cancer |
-
1993
- 1993-06-25 AU AU46452/93A patent/AU4645293A/en not_active Abandoned
- 1993-06-25 WO PCT/US1993/005952 patent/WO1994000764A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO1994000764A1 (en) | 1994-01-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2621092A (en) | A ventilation method and means for the same | |
IL104273A0 (en) | Double faced cutting insert | |
AU5543494A (en) | Method and kit for cancer diagnosis | |
AU4645293A (en) | The met proto-oncogene and a method for predicting breast cancer progression | |
AU1480497A (en) | Cancer treatment | |
GB9509572D0 (en) | Cancer therapy | |
AU3385693A (en) | Determination method | |
AU7166896A (en) | Cancer treatment | |
AU4309696A (en) | Compacts | |
AU3398793A (en) | Anti-tumor method and anti-tumor agent | |
GB9308166D0 (en) | Cancer therapy | |
EP0581283A3 (en) | Die coater | |
AU5414094A (en) | Antineoplastic heteronaphthoquinones | |
HU9201811D0 (en) | Processing technique | |
GB9306962D0 (en) | Partitioning | |
AU5165993A (en) | Pp14-based therapy | |
AU4261793A (en) | Wedge-welding method | |
GB9200089D0 (en) | Potentiometers | |
AU3377193A (en) | Sulphonylbenzyl-substituted imidazoles | |
AUPM458594A0 (en) | Partitioning | |
AU1493195A (en) | Partitioning | |
GB9520556D0 (en) | Digitiser tape | |
TW317202U (en) | Die coater | |
GB9218860D0 (en) | Steps | |
GB2302080B (en) | Gantry |